Clinical Trials Directory

Trials / Completed

CompletedNCT00797563

Evaluation of a New Blood Glucose Meter System With Capillary and Venous Blood

Clinical Evaluation of the Apollo Blood Glucose Monitoring System With Capillary and Venous Blood [Commercial Name is CONTOUR® USB]

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Ascensia Diabetes Care · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study was to evaluate the performance of the meter system in the hands of subjects and healthcare professionals (HCPs). It also evaluated the product user guides in the hands of untrained subjects.

Detailed description

The study evaluated the performance of the blood glucose meter system (BGMS) compared to a laboratory glucose method. Subjects and healthcare professionals tested subject capillary blood and healthcare professionals tested subject venous blood. Two meter configurations were evaluated. The study evaluated the acceptability of product labeling in enabling subjects to perform blood glucose testing with the new meter system and for using meter features. Subjects and healthcare professionals provided feedback about the BGMS and its features.

Conditions

Interventions

TypeNameDescription
DEVICEApollo Blood Glucose Monitoring SystemSubjects with diabetes use a new blood glucose monitoring system with capillary blood; healthcare professionals use the new blood glucose monitoring system with subject capillary and venous blood. All results are compared to a laboratory glucose method - Yellow Springs Instrument (YSI).

Timeline

Start date
2008-11-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2008-11-25
Last updated
2016-02-29
Results posted
2009-12-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00797563. Inclusion in this directory is not an endorsement.